Using advanced imaging to assess inflammation in bowel diseases

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of Texture and Color Enhancement Imaging (TXI) compared to standard White Light Endoscopy (WLE) in assessing inflammation in patients with Inflammatory Bowel Disease (IBD). Patients diagnosed with IBD will undergo ileocolonoscopy, where images will be captured using both TXI and WLE modes. The study aims to determine if TXI provides a non-inferior assessment of inflammatory activity, which is crucial for making informed treatment decisions. Biopsies will be taken, and various scoring systems will be utilized to validate the findings.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Histologically confirmed inflammatory bowel disease (ulcerative colitis or Crohn\'s disease)
* Age ≥ 18 years

Exclusion Criteria:

* Post (procto-) colectomy
* Endoscopically impassable stenosis in the left hemi-colon
* ASA status \> 2 points
* BBPS \< 6 points (or \< 2 points per segment)
* Severe coagulation disorder
* Pregnancy, lactation

Where it's running

• Ulm University Hospital
  Ulm, Baden-Wurttemberg, Germany Recruiting

Study contacts

• Study coordinator: Benjamin Michael Walter, Prof. Dr. med.
• Email: benjamin.walter@uniklinik-ulm.de
• Phone: +497315000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Intestinal ultrasound-guided management for inflammatory bowel disease

  This study tests if adding point-of-care intestinal ultrasound at every visit changes treatment decisions for adults with Crohn’s disease or ulcerative colitis undergoing disease assessment.

  Recruiting Mahidol University · Bangkok · NCT07775352

• Examining the link between polyamine levels and inflammatory bowel disease progression

  This study is trying to see if measuring certain substances in the body can help predict how inflammatory bowel diseases like Ulcerative Colitis and Crohn's Disease will progress in patients.

  Recruiting Xijing Hospital · Xi'an, Shaanxi · NCT06995170

• Evaluating inflammation in children with inflammatory bowel disease

  This study is testing a new device to see how it can help doctors understand inflammation in children with Crohn's disease and ulcerative colitis, so they can provide better treatment.

  Recruiting Children's National Research Institute · Washington D.C., District of Columbia · NCT06065228

• Resting energy use in kids with inflammatory bowel disease

  This multicenter study will test the resting energy expenditure of children aged 6–17 with new IBD diagnoses to see how it relates to disease activity and treatment.

  Recruiting Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria · Alessandria, Piedmont · NCT07670975

• Guselkumab in Breast Milk for Lactating Women on Guselkumab

  This study tests how much guselkumab is present in the breast milk of lactating women who are already receiving guselkumab for their approved conditions.

  Recruiting Phase 4 Janssen Research & Development, LLC · Chapel Hill, North Carolina · NCT07654751

• Guselkumab use in Crohn's disease and ulcerative colitis

  This study looks at how long people with moderate-to-severe Crohn's disease or ulcerative colitis stay on guselkumab in real-world care.

  Recruiting Janssen-Cilag Pharma GmbH · Vienna · NCT07606339

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.